Fraxiparine 2850IU Injection

Fraxiparine 2850IU Injection belongs to the class of ‘anticoagulants’ (blood thinners), primarily used to prevent and treat harmful blood clots. Fraxiparine 2850IU Injection is also used to prevent stroke or heart attack and deep vein thrombosis (blood clots in leg veins). It reduces the risk of blood clots in patients undergoing larger orthopaedic surgeries like elective hip surgeries. A blood clot can occur in any part of the body, leading to a heart attack, stroke and damage to organs (even coma or death). Blood clots can reach the arteries or veins in the organs like the brain, kidney, heart, lungs and limbs.

Fraxiparine 2850IU Injection contains ‘Nadroparin’ that belongs to the class of low molecular weight heparins (LMWHs). It works by inhibiting the production of clotting factors. This further prevents the conversion of fibrinogen (soluble protein) to fibrin (insoluble protein), thereby preventing blood clot formation. Fraxiparine 2850IU Injection helps in the free flow of blood through your veins, making it less likely to form a serious blood clot. 

Fraxiparine 2850IU Injection will be administered by a healthcare professional, do not self-administer. Your doctor will advise the dosage and duration of Fraxiparine 2850IU Injection based on your medical condition. The common side effects of Fraxiparine 2850IU Injection include easy bruising, injection site pain and swelling, mild irritation, weakness, numbness, dizziness, headache, and confusion. Most of these side effects of Fraxiparine 2850IU Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor. 

Do not stop taking Fraxiparine 2850IU Injection abruptly since it may worsen your condition and increase the risk of a future heart attack. Let your doctor know if you are allergic to Fraxiparine 2850IU Injection or have kidney/liver diseases and active bleeding issues (like peptic ulcer, brain haemorrhage). Fraxiparine 2850IU Injection is not recommended for use during pregnancy and breastfeeding; however, please seek medical advice. The patient should inform the doctor that they are taking Fraxiparine 2850IU Injection before any surgery is scheduled or any new medicine is taken. Please stay away from activities that may increase your risk of bleeding, like contact sports and using sharp objects like razors and nail cutters.

Fraxiparine 2850IU Injection is composed of Nadroparin, an anticoagulant or a blood thinner. It is low molecular weight heparin and prevents the formation of blood clots by inhibiting the production of clotting factors. It also reduces the risk of blood clots in patients undergoing larger orthopaedic surgeries like elective hip surgeries. Fraxiparine 2850IU Injection helps in the free flow of blood, thereby preventing the risk of heart attack, stroke, deep vein thrombosis (blood clot in the vein), and pulmonary embolism (blood clots in the arteries of lungs). Fraxiparine 2850IU Injection is used to prevent blood clotting in extracorporeal circulation (apparatus carrying the blood outside the body) during haemodialysis (purifying blood in a person whose kidney are abnormally functioning) and hemofiltration (renal replacement therapy) processes.

• Easy bruising
• Injection site pain and swelling
• Mild irritation
• Weakness
• Numbness
• Dizziness
• Headache
• Confusion

Before taking Fraxiparine 2850IU Injection, let your doctor know if you have a history of liver and kidney diseases or allergic reactions to Fraxiparine 2850IU Injection. Inform your doctor beforehand if you have a risk of internal bleeding (stomach ulcer), blood disorders (bleeding inside any tissues, organs or joints of your body), a recent injury/surgery or a planned surgery (including dental) in the next few days, a clot in an artery of your brain (ischaemic stroke), eye problems like diabetic retinopathy, spinal problems, artificial heart valves, and high blood pressure. Fraxiparine 2850IU Injection is not recommended for use during pregnancy and breastfeeding; however, please seek medical advice. Try avoiding alcohol to prevent any side effects’ occurrence further. If you experience dizziness, do not drive or operate machinery. Fraxiparine 2850IU Injection is not recommended in people younger than 18 years of age. Store Fraxiparine 2850IU Injection at temperatures not exceeding 25°C.

Drug-Drug Interaction: Fraxiparine 2850IU Injection may interact with other blood thinners (clopidogrel, ticlopidine), pain killers, corticosteroids, abortion drugs (mifepristone), and blood pressure medicines (benazepril, captopril).

Drug-Food Interaction: Limit alcohol intake since it may cause a rise in blood pressure leading to heart diseases. Avoid fatty foods and control your cholesterol and triglyceride levels.

Drug-Disease Interaction: Brief your doctor if you have a medical history of heart diseases, active bleeding disorders, ischaemic stroke, diabetic retinopathy, spinal problems, artificial heart valves, high blood pressure, liver, and kidney diseases before taking Fraxiparine 2850IU Injection.

• CLOPIDOGREL
• TICLOPIDINE
• BENAZEPRIL
• CAPTOPRIL
• MIFEPRISTONE

• Take the medication as directed by the doctor and at regular intervals. Do not use other over the counter medications, herbal or vitamin supplements without informing your pharmacist or doctor when you take Fraxiparine 2850IU Injection.
• Avoid vitamin K rich foods such as coriander, cabbage, spinach, broccoli, collard greens, kale (leaf cabbage), black liquorice, turnip greens, avocados, Brussels sprouts as they may decrease the effectiveness of Fraxiparine 2850IU Injection.
• Keep your cholesterol and triglyceride levels under control.
• Eat at regular intervals and maintain a healthy diet that includes fresh fruits and vegetables
• Limit alcohol intake since it raises blood pressure and increases the risk of heart diseases
• Keep a check on your weight and exercise regularly to keep your heart healthy.
• Your doctor also guides you on noticing and managing the early symptoms of detecting heart diseases. 

Since Fraxiparine 2850IU Injection may affect liver enzymes, your doctor may suggest liver function tests to check your aspartate aminotransferase (AST), alanine aminotransferase (ALT), and bilirubin levels before starting treatment and every two weeks after the treatment with Fraxiparine 2850IU Injection.

A blood clot is a clump of blood that has changed from liquid to gel-like or semisolid state. Blood clots are formed to stop bleeding that occurs due to tissue injury. Though blood clots are useful to stop bleeding, they may be harmful when abnormally formed within the blood vessels, restricting the blood flow to essential organs, such as the brain, heart, or lungs, resulting in severe conditions.

Deep vein thrombosis (blood clots in legs) is a medical condition in which blood clots form in deep veins, usually in the legs. The symptoms include leg pain or swelling. 

A heart attack occurs when a blood clot blocks the blood flow to the heart. This blockage of arteries is often an accumulation of fat, cholesterol and other substances, which form a plaque in the arteries that feed the heart (coronary arteries). Signs of a heart attack include chest pain, upper body pain, sweating, nausea, fatigue and trouble breathing.